Improving efficacy of cancer immunotherapy through targeting of macrophages by Elisa Peranzoni, Emmanuel Donnadieu

Get full text

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade by Elisa Peranzoni, Vincenzo Ingangi, Elena Masetto, Laura Pinton, Ilaria Marigo

Get full text

Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen by Stefano Ugel, Elisa Peranzoni, Giacomo Desantis, Mariacristina Chioda, Steffen Walter, Toni Weinschenk, Jordi C. Ochando, Anna Cabrelle, Susanna Mandruzzato, Vincenzo Bronte

Get full text

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma by Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli

Get full text

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression by Julia M. Weiss, Marion V. Guérin, Fabienne Regnier, Gilles Renault, Isabelle Galy-Fauroux, Lene Vimeux, Vincent Feuillet, Elisa Peranzoni, Maxime Thoreau, Alain Trautmann, Nadège Bercovici

Get full text

Peptide‐Drug Conjugate for Therapeutic Reprogramming of Tumor‐Associated Macrophages in Breast Cancer by Anni Lepland, Elisa Peranzoni, Uku Haljasorg, Eliana K. Asciutto, Maria Crespí‐Amer, Lorenzo Modesti, Kalle Kilk, Manuel Lombardia, Gerardo Acosta, Miriam Royo, Pärt Peterson, Ilaria Marigo, Tambet Teesalu, Pablo Scodeller

Get full text